Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elena G Chiorean

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
The Oncologist|June 24, 2006
Locally advanced pancreatic cancer: current therapeutic approachHiginia R Cardenes, Elena G Chiorean, John Dewitt, et al.
Journal of Surgical Oncology|June 23, 2009
Non-ampullary duodenal adenocarcinoma: factors important for relapse and survivalAaron Struck, Thomas Howard, Elena G Chiorean, et al.
Blood|January 4, 2003
BCR/ABL alters the function of NK cells and the acquisition of killer immunoglobulin-like receptors (KIRs)Elena G Chiorean, Scott J Dylla, Krista Olsen, et al.
Radiology|June 3, 2010
Pancreatic cancer: utility of dynamic contrast-enhanced MR imaging in assessment of antiangiogenic therapyM Fatih Akisik, Kumaresan Sandrasegaran, Guixue Bu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2003
Trastuzumab and interleukin-2 in HER2-positive metastatic breast cancer: a pilot studyTanya Repka, Elena G Chiorean, Juliette Gay, et al.
Clinical Genitourinary Cancer|June 25, 2011
Retrospective analysis of satraplatin in patients with metastatic urothelial cancer refractory to standard platinum-based chemotherapyMatthew D Galsky, Sonia Seng, Luis H Camacho, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 3, 2004
Donor chimerism does not predict response to donor lymphocyte infusion for relapsed chronic myelogenous leukemia after allogeneic hematopoietic cell transplantationElena G Chiorean, Todd E DeFor, Daniel J Weisdorf, et al.
Molecular Cancer Therapeutics|November 29, 2012
Plk1 phosphorylation of orc2 and hbo1 contributes to gemcitabine resistance in pancreatic cancerBing Song, X Shawn Liu, Steven J Rice, et al.
American Journal of Clinical Oncology|August 19, 2009
A phase 2 trial of glufosfamide in combination with gemcitabine in chemotherapy-naive pancreatic adenocarcinomaElena G Chiorean, Tomislav Dragovich, John Hamm, et al.
Plos One|March 2, 2013
Elevated phospholipase A2 activities in plasma samples from multiple cancersHui Cai, Elena G Chiorean, Michael V Chiorean, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
The Oncologist|June 24, 2006
Locally advanced pancreatic cancer: current therapeutic approachHiginia R Cardenes, Elena G Chiorean, John Dewitt, et al.
Journal of Surgical Oncology|June 23, 2009
Non-ampullary duodenal adenocarcinoma: factors important for relapse and survivalAaron Struck, Thomas Howard, Elena G Chiorean, et al.
Blood|January 4, 2003
BCR/ABL alters the function of NK cells and the acquisition of killer immunoglobulin-like receptors (KIRs)Elena G Chiorean, Scott J Dylla, Krista Olsen, et al.
Radiology|June 3, 2010
Pancreatic cancer: utility of dynamic contrast-enhanced MR imaging in assessment of antiangiogenic therapyM Fatih Akisik, Kumaresan Sandrasegaran, Guixue Bu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2003
Trastuzumab and interleukin-2 in HER2-positive metastatic breast cancer: a pilot studyTanya Repka, Elena G Chiorean, Juliette Gay, et al.
Clinical Genitourinary Cancer|June 25, 2011
Retrospective analysis of satraplatin in patients with metastatic urothelial cancer refractory to standard platinum-based chemotherapyMatthew D Galsky, Sonia Seng, Luis H Camacho, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 3, 2004
Donor chimerism does not predict response to donor lymphocyte infusion for relapsed chronic myelogenous leukemia after allogeneic hematopoietic cell transplantationElena G Chiorean, Todd E DeFor, Daniel J Weisdorf, et al.
Molecular Cancer Therapeutics|November 29, 2012
Plk1 phosphorylation of orc2 and hbo1 contributes to gemcitabine resistance in pancreatic cancerBing Song, X Shawn Liu, Steven J Rice, et al.
American Journal of Clinical Oncology|August 19, 2009
A phase 2 trial of glufosfamide in combination with gemcitabine in chemotherapy-naive pancreatic adenocarcinomaElena G Chiorean, Tomislav Dragovich, John Hamm, et al.
Plos One|March 2, 2013
Elevated phospholipase A2 activities in plasma samples from multiple cancersHui Cai, Elena G Chiorean, Michael V Chiorean, et al.
Pageof 2